Loading...
Uploaded by StaffordJim on May 21, 2009
Dr. Paul DeAngelis discusses a new sugar-based drug delivery platform he created in his University of Oklahoma laboratory and the new company, Caisson Biotech, that has been created to commercialize the technology.
Education
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)